v3.26.1
Commitments and Contingencies - Additional Information (Details) - USD ($)
 3 Months Ended 12 Months Ended
Jul. 15, 2025
Feb. 21, 2024
Dec. 22, 2016
Nov. 20, 2014
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2021
Jul. 01, 2025
Apr. 11, 2025
Mar. 04, 2025
Commitments and Contingencies [Line Items]                        
Expenditures amount       $ 265,000                
Other long-term liabilities         $ 0     $ 330,000        
Revenues         398,000   $ 381,000          
License fee       5,000 0     0        
Cash payment       $ 50,000                
Agreement term       20 years                
Milestone payment         500,000              
Milestone fees payable         7,500     7,500        
Annual net sales percentage     1.00%                  
Payment of royalty from the first commercial sale in period     10 years                  
Percentage of decrease in royalty     50.00%                  
Net sales of sub licensees percentage     10.00%                  
Payment of extension fee     $ 5,000                  
Award amount         $ 3,000,000              
U. S. Food And Administration [Member]                        
Commitments and Contingencies [Line Items]                        
Milestone acievement period on approval of the last commercialized product     20 years                  
Supply Agreement [Member] | Secretome [Member]                        
Commitments and Contingencies [Line Items]                        
Agreement term   5 years                    
Agreement termination description         Either party may terminate the agreement for cause and upon notice in the event of a material breach, within (i) 30 days of an uncured material breach that is not a payment default or (ii) 10 days for an uncured payment default. The Secretome Agreement further provides that either party may terminate the agreement at any time upon 90 days’ notice to the other party.              
Revenues         $ 20,000   $ 100,000          
UM Agreements [Member]                        
Commitments and Contingencies [Line Items]                        
Payments to UM         5,000              
UM License [Member]                        
Commitments and Contingencies [Line Items]                        
License fee                 $ 100,000      
Payments to UM         500,000              
first Phase 3 Clinical Trial [Member]                        
Commitments and Contingencies [Line Items]                        
Completion of trial       $ 150,000                
Biologics license [Member]                        
Commitments and Contingencies [Line Items]                        
License fee       $ 250,000                
Chief Science Officer [Member]                        
Commitments and Contingencies [Line Items]                        
Accrued consulting fees                     $ 45,000  
Performance bonus                     $ 131,000  
Consulting fees earned           $ 30,000            
Other long-term liabilities         $ 300,000     $ 300,000        
Class A Common Stock [Member]                        
Commitments and Contingencies [Line Items]                        
Unregistered shares (in Shares)       11,039                
Class A Common Stock [Member] | Chief Science Officer [Member]                        
Commitments and Contingencies [Line Items]                        
Options to purchase common stock                     184,878 71,254
Granted options to purchase common stock 109,000                      
Fully vested options to purchase shares of common stock                   49,219    
Exercise price per share $ 1.47                      
Options vesting period 3 years